Stocks to watch today, February 13: Track the latest stock updates and key Q3 results before the budget—discover which stocks…
US slashes tariffs on Indian goods to 18%, boosting exports and investments. Axis Direct identifies top 25 Indian stocks in…
Kotak adds ITC and Max Healthcare, drops Embassy REIT and Lupin from its model portfolio — see the full list…
Motilal Oswal sees value in four stocks VA Tech Wabag, V-Mart, Zydus Wellness, and Shriram Finance citing strong earnings visibility…
A revolution in India’s weight-loss market is coming. As Semaglutide’s patent ends in 2026, Sun Pharma, Lupin, Torrent, and Intas…
Stocks to watch today, December 30: Track key updates on IndiGo, Hindalco, RVNL, and more top stocks today—get the latest…
Explore Religare Broking’s top 5 stock picks for 2026, each poised for double-digit growth—see which stocks could boost your portfolio…
Two of the Big Whale Ashish Kacholia’s biggest holdings are strong contenders for the Watchlist 2026, with their stock prices…
Stay updated on key stocks as Airtel, HCLTech, Lupin, BLS, and more announce major deals, contracts, and board decisions—read the…
From generics to branded drugs, Jefferies’ latest pharma calls spotlight Alkem, Lupin, Sun Pharma, Torrent, and Zydus as India’s key…
The Indian equity market has shown a strong rebound since early October 2025. The Nifty50 has delivered a return of…
Jefferies maintains ‘Buy’ ratings on LG Electronics, Lupin, and Mahindra & Mahindra; discover why these stocks offer up to 21%…
Track 9 key stocks like Tata Motors, Maruti Suzuki, and Kotak Bank for market movers and earnings updates—see which stocks…
Seasonality suggests November softness and December strength, yet select Pharma counters consistently outperform. Three stocks offering the favourable risk-reward from…
Track key stocks like LIC, Infosys, and Lupin after their latest results and major announcements—get the latest market movers now!
Global pharma major Lupin is accelerating its digital transformation to streamline operations, hasten drug discovery, and champion patient-centricity.
Indian pharma stocks, including Aurobindo Pharma and Lupin, surged after reports indicated the US Administration is considering excluding generic medicines…
Track midday stock movers like TCS, Prestige Estates, and Lupin as key earnings and project updates drive market momentum—see full…